| Phase 4 |
| NCT07691125 |
Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome |
Short Bowel Syndrome (SBS) in Adults |
Recruiting |
2026-07-08 |
| NCT07243379 |
A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in… |
Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia |
Recruiting |
2025-11-21 |
| Phase 3 |
| NCT07124221 |
A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate… |
Hyperprolactinemia |
Recruiting |
2025-10-02 |
| NCT07150663 |
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced… |
Non-small Cell Lung Cancer |
Recruiting |
2025-09-08 |
| NCT07841678 |
A Phase III Clinical Study of Jinpei Growth Hormone Injection in the Treatment of Short… |
Small for Gestational Age |
Not Yet Recruiting |
2026-09-25 |
| NCT07356037 |
Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular… |
Cachexia |
Not Yet Recruiting |
2026-01-21 |
| NCT06449027 |
Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for… |
Breast Cancer Subjects |
Active, Not Recruiting |
2025-10-01 |
| NCT06961188 |
Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight… |
Metastatic (Stage IV) Non-squamous Non-small Cell Lung Cancer (Nsq-NSCLC) With Driver Gene Negativity |
Not Yet Recruiting |
2025-05-07 |
| NCT06961201 |
Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard… |
Extensive-stage Small Cell Lung Cancer (ES-SCLC) |
Not Yet Recruiting |
2025-05-07 |
| NCT06772428 |
Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck… |
Head and Neck Squamous Cell Carcinoma; Underwent Surgery Within 6 Weeks and Postoperative Assessment Indicated High-risk Factors |
Not Yet Recruiting |
2025-01-13 |
| NCT06561594 |
To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection… |
Idiopathic Hypogonadotropic Hypogonadism |
Not Yet Recruiting |
2024-08-20 |
| Phase 2 |
| NCT07547995 |
A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis. |
Uveitis |
Recruiting |
2026-07-24 |
| NCT07423533 |
Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in… |
Rheumatoid Arthritis |
Recruiting |
2026-05-22 |
| NCT07260500 |
A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age… |
Short Stature Children Born Small for Gestational Age (SGA) |
Recruiting |
2026-02-17 |
| NCT06963177 |
A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients… |
Endometriosis-related Pain |
Recruiting |
2025-08-12 |
| NCT06189495 |
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the… |
Systemic Sclerosis Associated Interstitial Lung Disease |
Recruiting |
2025-01-17 |
| NCT03255694 |
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of… |
Dwarfism |
Active, Not Recruiting |
2025-08-15 |
| NCT02375620 |
Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short… |
Short Stature Children Born Small for Gestational Age (SGA) |
Active, Not Recruiting |
2025-05-25 |
| Phase 1/2 |
| NCT07264595 |
A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone… |
Pediatric Growth Hormone Deficiency |
Recruiting |
2026-09-16 |
| NCT07450001 |
A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD) |
Pediatric Growth Hormone Deficiency |
Not Yet Recruiting |
2026-03-04 |
| NCT07450053 |
A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS) |
Idiopathic Short Stature |
Not Yet Recruiting |
2026-03-04 |
| Phase 1 |
| NCT07663838 |
A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the… |
Randomized |
Recruiting |
2026-10-15 |
| NCT07366866 |
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults. |
Autoimmune Disease |
Recruiting |
2026-10-14 |
| NCT07407504 |
GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated… |
Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated |
Recruiting |
2026-09-25 |
| NCT07685210 |
GenSci144 Tablets Phase I Clinical Trial |
Phenylketonuria |
Recruiting |
2026-07-06 |